Gemtuzumab (Anti-Siglec-3 / CD33)
Catalog #: bp-50174
-
Overview
Gemtuzumab (Anti-Siglec-3 / CD33) a monoclonal antibody targeting CD33 antigen, which present on the human leukemic myeloblasts of acute myeloid leukemia (AML). It can be used as antibody-drug conjugate for the treatment of AML. This biosimilar antibody is used for research only. MW :145.22 KD.Product Details Species Reactivity Human Host/Isotype Human IgG4 Class Monoclonal Type Recombinant Antibody Immunogen Human CD33 Clone Gemtuzumab biosimilar Conjugate Unconjugated Purity 99% Molecular Weight 145.22 KD Protein Concentration 1mg/ml Storage Condition Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. Storage Buffer 100mM Pro-Ac, 20mM Arg-Ac, pH 5.0 -
Images
-
Datasheets and Documents